Furthermore, antibody targeting of NGF (nerve growth factor) or small molecule blocking of NGF‐Trk pathway led to inhibition of cancer progression and increased overall mice survival in LSL‐Kras+/G12D; LSL‐Trp53+/R172H; Pdx1‐Cre (KPC) mouse model (Renz et al., 2018b; Saloman et al., 2018). This evidence concerns the gene NGF and cancer.